Each year, billions of dollars are spent on medical research and development to better understand and treat various diseases. How much of this…
TEL AVIV, Israel, Dec. 27, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty…
Formulated with 90% naturally-derived ingredients and Dermal Precision Technology to maximise absorption and minimise irritation
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 27, 2024--
– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing observed –
TOKYO--(BUSINESS WIRE)--Dec 25, 2024--
BOSTON--(BUSINESS WIRE)--Dec 23, 2024--
AUSTIN, Texas, Dec. 23, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today data that it is halting its clinical program in rheum…
A decongestant pill containing phenylephrine is displayed for a photograph in Philadelphia on Monday, Dec. 9, 2024. (AP Photo/Jonathan Poet)
Decongestant pills containing phenylephrine are displayed for a photograph in Philadelphia on Monday, Dec. 9, 2024. (AP Photo/Jonathan Poet)
